rimexolone
Sign in to saveAlso known as Vexol
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye. It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories, but was discontinued in the US and other countries.
Research
54 papers- Rimexolone.2006
- Rimexolone-induced intraocular pressure elevation.Eye (London, England) · 2001
- PMID 18031088BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy · 1997
- Rimexolone inhibits proliferation, cytokine expression and signal transduction of human CD4+ T-cells.Immunology letters · 2010
- Intraocular pressure-raising potential of 1.0% rimexolone in patients responding to corticosteroids.Archives of ophthalmology (Chicago, Ill. : 1960) · 1996
via PubMed
~2 min read
Encyclopedic overview
7 sectionsContents
- Medical uses
- Contraindications
- Side effects
- Pharmacology
- Pharmacodynamics
- Pharmacokinetics
- References
Rimexolone is a glucocorticoid steroid used to treat inflammation in the eye. It is marketed as a 1% eye drop suspension under the trade name Vexol by Alcon Laboratories, but was discontinued in the US and other countries.
==Medical uses== Rimexolone is used to treat inflammation after eye surgery, to treat anterior uveitis, conjunctivitis and keratitis.
Excerpted from Wikipedia’s “rimexolone” article, available under the CC BY-SA 4.0 licence.